Cite
[Treat-and-extend anti-angiogenic protocol in clinical practice for patients with exudative age-related macular degeneration: Consensus of French experts].
MLA
Baillif, S., et al. “[Treat-and-Extend Anti-Angiogenic Protocol in Clinical Practice for Patients with Exudative Age-Related Macular Degeneration: Consensus of French Experts].” Journal Francais d’ophtalmologie, vol. 44, no. 1, Jan. 2021, pp. 1–12. EBSCOhost, https://doi.org/10.1016/j.jfo.2020.03.017.
APA
Baillif, S., Creuzot-Garcher, C., Dot, C., Kodjikian, L., Matonti, F., Mrejen, S., Nghiem-Buffet, S., Semoun, O., & Tadayoni, R. (2021). [Treat-and-extend anti-angiogenic protocol in clinical practice for patients with exudative age-related macular degeneration: Consensus of French experts]. Journal Francais d’ophtalmologie, 44(1), 1–12. https://doi.org/10.1016/j.jfo.2020.03.017
Chicago
Baillif, S, C Creuzot-Garcher, C Dot, L Kodjikian, F Matonti, S Mrejen, S Nghiem-Buffet, O Semoun, and R Tadayoni. 2021. “[Treat-and-Extend Anti-Angiogenic Protocol in Clinical Practice for Patients with Exudative Age-Related Macular Degeneration: Consensus of French Experts].” Journal Francais d’ophtalmologie 44 (1): 1–12. doi:10.1016/j.jfo.2020.03.017.